Serrantor OCT Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Serrantor OCT Study — Stella

Home/Critical Limb Ischemia/

View on ClinicalTrials.gov

Recruiting

Back to Critical Limb Ischemia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Columbia University, New York, New York

Weill Cornell Medical, New York, New York

Key details

Sponsor

Cagent Vascular LLC

Enrollment target

~60 participants

Started

October 2024

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.